Psoriatic patients have a decreased proportion of mon ocytes expressin g class II m ajor histocompatibility complex antigens (DR + m onocytes) in their peripheral bl ood . The expression of the DR anti gen on monocytes after culture in the presence of either autologous lymphocytes (endogenous interferon-gamma, IFN--y) or exogenous IFN--y was inves ti gated . In normal AB serum the lymphocytes of the maj ority of th e patients showed a spontaneous IFN--y production which was sufficient for DR anti gen induction , while the m onocytes displayed approximate normal sus-R ecentl y, much attention has been focused on the fac t that interferon (IFN) regulates the expressio n of histocompatibility antigens (MHC antigens) in severa l cell types [1 ,2]. It has been shown that the expression of class II MH C antigens o n J11 o nocytes/ m acrophages, a feature critical to the antigen-presentin g fun ction of these cells, is reg ul ated by 3] .
Psoriatic patients have a decreased proportion of mon ocytes expressin g class II m ajor histocompatibility complex antigens (DR + m onocytes) in their peripheral bl ood . The expression of the DR anti gen on monocytes after culture in the presence of either autologous lymphocytes (endogenous interferon-gamma, IFN--y) or exogenous IFN--y was inves ti gated . In normal AB serum the lymphocytes of the maj ority of th e patients showed a spontaneous IFN--y production which was sufficient for DR anti gen induction , while the m onocytes displayed approximate normal sus-R ecentl y, much attention has been focused on the fac t that interferon (IFN) regulates the expressio n of histocompatibility antigens (MHC antigens) in severa l cell types [1 ,2] . It has been shown that the expression of class II MH C antigens o n J11 o nocytes/ m acrophages, a feature critical to the antigen-presentin g fun ction of these cells, is reg ul ated by IFN-y [2, 3] .
In psoriasis, several ab norm al functions of immune cells simil ar to those found in patients sufferin g from the classical autoimmune diseases, h ave been described [4] [5] [6] . Recently, IFN-like activity has been detected in suction blister Auid fr o m lesions [7] and in the peripheral blood [8] of patients sufferin g from psoriasis. Similar findings have been published for systemic lupus erythematosus [9] . Furthermore, we h ave foun d that the mitogen-indu ced production of IFN-y by peripheral blood cells of the patients, was significa ntl y reduced , and som e of these patients failed completely to produce IFN-y in vitro [4] , as did patients suffering from several autoi mmune diseases [5] . This prom pted us to look for the class II MHC (DR) antigen expression in the peripheral blood monocytes both in vivo and in vitro after cultivation in the presence of added IFN-y. Our findings, described in this paper, show that patients su ffering from psoriasis have a decreased proportion of DR + m o nocytes in their periphera l bl ood . Three explan ations are proposed for o ur observation: (1) diminished IFN-y production by patients' lymp hocytes; (2) impaired susceptibility to IFN-y; and (3) the existen ce of soluble factors that inhibit the action of IFN-y on mon ocy tes. T he res ults suggest that the third possibility is most likely to be true.
MATERIALS AND M ETHODS
Patients The heparini zed bloo d was obtained from hospital pati ents with exacerbating psoriatic lesions. Blood samples were draw n before the patients h ad undergon e any internal therapy or PUV A treatment. H ealthy volunteers matched for age and sex were used as controls.
Preparation of Monocytes T he mono nuclear cells were isolated from hepa rini zed blood sa mples by density gradient centrifugation as described [1 0] . The cells were resuspendend in culture medium RPMI-1 640 (Sifin , Berlin , G .D .R.), supplem ented with L-glutamine 2 mM, penicillin 100 U / ml , streptomycin 100 ILg/ ml , and 10% hea t-inactiva ted AB seru m or fetal calf serum (FCS) . FCS-coated glass coverlips were placed in P etri dishes and overl aid with the cell suspension (5 X 10 6 / ml) . After in cubati on at 37°C for 2 h , the n onad herent cell s we re rem.oved by repeated washing with prewarmed m edium (6-8 times). T he coveriips with the adherent cells were either assayed immed iately or incubated further in 2 ml of fresh culture medium in P etri dishes; th e adherent cells consisted of more th an 93% m o nocytes charac terized by no nspecific esterase and Au orescen ce staining using a mon oclonal antimo nocyte antibody (BL-M/G). Less than 3% ofT ly mphocytes, as assayed by stainin g with a m o n oclonal pan-T cell an tibody (BL-T2) , we re usuall y observed am on g the adherent cells. One to four days later, the number of adh erent cells dro pped by an average of only 10-15% . During culti vation, a part of the adherent cells acq uired the m o rphologic appearance of m ature large " histiocy te-like" cells. After 3 days in culture, the ad herent cells displ ayed o nl y a minim al contaminatio n by cell s other than m onocytes/ m ac ro phages (th ey were m o re than 98% BL-M /G) , and no T lymphocytes co uld be detected .
Surface Antigens Prior to the stainin g of cell s, the medium was asp irated and replaced b y 1 % parafo nn aldeh yde solu tion fo r 15 min at rQom temperature. T he cell s were then was hed twi ce and overl aid w ith isotoni c buffer so luti o n (PBS) con tainin g 2% bovine serUJ11 albLlmin. Afte r 15 min th e so lu tio n was rem oved and · the cells were in cubated w ith t he app ro priate mo noclonal antibo dies . After was hin g, th e coverslips were ih cubated w ith a fluoresce in-co nju ga ted goa t an ti m ouse antiserum di luted 1: 40 in PBS . T he cell s wer<~ then studi ed und er a Ru o rescent microsco pe Oenalum ar, Ca rl -Zeiss J ena, G . D.R.) . At leas t 200 cells were co unted each tim e.
Monoclonal Antibodies (Mab) T he data of the utilized Mab h ave been described in detail else wh ere [11 , 12] . B ri eRy, BL-T2 containin g 10% AB serum for 3 days. Therea ft er, the DR antigen expression on 1110n ocy tes was determin ed. As show n in Table I , the Iy mph ocyt.es of the majority of the pati ents produced sufficient am o unts o fIFN-y for conservation of DR antigen express ion on cultured mo nocytes. Onl y 3 of8 pati ents showed a decrcJsed spontan eous IFN-y produ ctio n in thi s assay. T herefore, it seems unlikel y th at a d iminished IFN-y produ ction is the so le reason for t he decreased DR antigen ex pressio n o n mo nocytes o f psonatl c patIents 111 V I VO .
Susceptibility to IFN-y In Vitro The percen ta ge of 111 0no-cytes ex pressin g DR anti gehs decreased within 3 days of culture both in hea lth y do nOl's and pso riatic pati ents. W hen 10 IU / ml (7) 60 (8) 25 (7) Pso ria tic Pati ents
(15) NOh
Highl y purifi ed monocy tes (IO'/ wel l) were cultured in mediulll \vith iO% All serulll and va rio us supplem ents for 3 days; therea fter. the DR antigen e. 'press ion o n lh e 1ll 0 1l 0C)' t c s was dete rmined . In the absen ce o r :ll1y IFN-y a slope in Dn anti gen expression was observed. In the presence o f either 5 IU / IlIII FN--y (exogelWus IFN --y) o r 5 X 10' all to logous lymphocytes per well (endogeno us IFN --y) the loss o f D R a/!l igens was prevented. The DR anti gen-preserving effe ct o f added lymphocy tes is caused by sponta neous IFN -y sy nthesis. because a Mab aga inst IFN--y was able to abolish this effecl.
"Mean (SO). n = 8. 'Not dO lle.
IFN-y was added to cu ltures containin g AB seru m , the values remained significan tl y higher in bo th groups (Fig 2a) , w hereas IFN-O' (1-500 IU / ml) additio n had no effect (not shown). T he margina l difference between the health y group (68 ± 8%) and the patient group (56 ± 11 %) was not signifi ca nt (p > 0.05).
Th us, the susceptibili ty of patients' mo nocytes to IFN-y with regard to DR anti ge n ind ucti o n seems to be norma l. However, as shown in Fig 2b, the action of IFN-y was prevented by autologous se rum (10%) in 10 of 12 patients (24 ± 13% ). This inhibito ry activity in the patients' sera was not geneti call y restricted sin ce sera of psoriatic patients also reduced the DR antigen exp ression on several allogeneic monocytes (not shown) . H owever, the IFN-y effect o n monocytes of heal th y do no rs was rarely inAuenced by the sera of patients; in o nl y 3 of 12 hea lthy donors the proportion of DR + monocytes was signifi can tl y decreased by sera of patients in the presence of IFN-y. T he mean value of DR + monocytes of healthy donors in th e presence of both IFN-y and sera of patients was 58 ± 12%, that is, 15% inhibition vs 57% inhibition in the group of psoriatic patients (p < 0.01).
Characteristics of the Inhibitory Activity in the Sera of Psoriatic Patients It has been show n that prostaglandins (PG) of the E series inhibit the IFN-y effect on class (( MHC antige n expression on rnonocytes/macrophages [1 ,13] . Furthermore, we have demonstrated that reactive oxygen intermediates induced by phagocytosis also red uced the DR antigen expressio n on monocytes 11 31. We tested whether the inhibitory activity in the sera of patients cou ld be abolished by the addition of reducing agents such as 2-mercaptoethano l, scavengers of reactive oxygen intermediates su ch as SOD and /3-ca rotene, o r the inhibitor of PGE synt hesis , indomethacin. As shown in Tab le II, the inhibitory effect of the sera of psoriati c patients on the If N-y-med iated DR anti gen expression ca n be prevented by SOD, 2-m ercaptoethanol, an.d indo meth acin.
Stud ies on the kinetics of the DR antigen suppression by these sera revealed tl"\at w hen sera of psoriatic patients were added to the monocyte cu ltu res 1 day latq than IFN-y, no suppressive effect was observed (data not shown) .
D ISC U SS IO N
Peri phera l blood monocyte;; from patients sufferin g fro m psori as is expressed fewer DR antigens on their surfaces than m onocytes from hea lthy donors (Fig 1) . In order to explain this, we M onocytes of psoriatic patients ( l OS/ wel l) were cultu red in the presen ce of 10 IU / ",I IFN--y and either normal AB seru m or auto logous seru", for 3 days. T he supplements were added o n day O.
' M ea n (SD). n = 5.
tried to detect disturbances in the production o r fun ction of IFNy o n psoriatic patients. The results sho w that an insuffi cient IFN-y synthesis by ly mphocytes (Table I) and /o r a dimini shed IFN-y res po nse by monocytes (Fig 2a) Indeed. the cyClooxygenase inhibitor indo m ethacin prevented the inhibitory effect of these sera (Table II) , and this could indicate that the indu ction of PG synthesis in the mo nocytes of psoriati c patients by their sera co uld be the ca use of the inhibiti on of the DR antigen expression. Evidentl y, the IFN-y effect on m onocytes of hea lth y don ors was only rarely affec ted by the sera of pso ri atic patients. O bviously, the monocytes of hea lth y volunteers are mo re resistant to the inhibitory sig nal m ed iated by the patients' sera and that can impl y that monocytes of psoriatic patients differ from those of no rmal persons in their functional state.
The nature of th e inhibitory factor(s) is not clear. The serummediated DR an tigen inhibition ca n be prevei1ted b y add itio n of 2-mercaptoethanol or SOD (Table II) . This effect is of special int~res t as it im.plicatcs a m echanism analogous to the conca navalin A-derived ,so luble immune res po nse suppressor (SIRS), a 55;000-dalton g lycoprotein produced b y conca navalin A-activated T cells which blocks antibody response and mitogen-indu ced pro liferation in vitro and in vivo [14. 15] . It is rel eased by suppressor T cells in an inert precurso r form and is converted into the active moiety upon oxidation b y H 2 0 2 derived from stimulated monocytes [14] . T he inhibito ry effect o f SIRS on various immune functions can be inhibited by reagents which suppress the formation of the monocyte-modified soluble factor (catalase, cyanide) or in activa te it (~educing age nts like 2-m erca ptoethariol) [14.15] . The SIRS ca n also induce PGE synthesis [14] . Remarkably , SIRS ca n be produced by T cells in cubated with IFN-O' instead of cOllcariavaliri A [14] .
Recently. IFN-Iike activity has been detected in bo th the skin and the blood of psoriati c patients [7.8] . The presence of IFN in the circul atio n is possibly responsible for th e production of a SIRS-like lympho kii1 e by the lymphocytes of patients; acti vated further by monocy tes, this active moiety is probably able to induce PGE synthesis in mo nocytes. and that could pro vide us with an explanation for the decreased proportion of DR + monocytes in psori atic patients described above. Since similar defects in DR antigen expression on mo nocytes are observed in quite disparate conditio ns like systemic lupus erythematosus. infections with My cobacterium lepra e. sepsis. and psoriasis [1. [16] [17] [18] , it is quite unlikely that they are the actual cause of the disease. The possibility that a chronic inflammatory process so m ehow leads to these effects is at least as likely. These observed phenomena may be the expression of an attempted contraregu lation against the autoimmune and/or chronic inflammatory process in the organism. An effective therapy of psoriasis co uld be 3n enhancement of the n a tural regulatory processes, if we know more about them . At present, we are studying the mediators of biologic immunosuppression and the mechanisms of their induction.
Experiments are in progress to investigate whether the effects described in this paper are also detectable in the skin (epiderma l cell culture, suction blister fluid).
